Hong Kong Luxury Stock News

China State Construction International Holdings ( HKG:3311 ) First Half 2025 Results Key Financial Results Revenue...

Dream International Limited ( HKG:1126 ) will pay a dividend of HK$0.25 on the 13th of October. This makes the dividend...

Ming Fai International Holdings Limited ( HKG:3828 ) has announced that it will pay a dividend of HK$0.03 per share on...

CK Asset Holdings Limited ( HKG:1113 ) stock is about to trade ex-dividend in four days. The ex-dividend date is...

When close to half the companies in the Semiconductor industry in Hong Kong have price-to-sales ratios (or "P/S") below...

Lotus Horizon Holdings Limited's ( HKG:6063 ) price-to-sales (or "P/S") ratio of 1.4x may not look like an appealing...

China Unicom (Hong Kong) Limited's ( HKG:762 ) robust earnings report didn't manage to move the market for its stock...

ZhongAn Online P & C Insurance Co., Ltd.'s ( HKG:6060 ) price-to-earnings (or "P/E") ratio of 23.3x might make it look...

As global markets navigate a period of economic uncertainty, with mixed signals from major economies such as the U.S. and China, investors are increasingly looking toward Asia for opportunities in growth stocks. In this context, companies with high insider ownership can offer an added layer of confidence, as significant insider stakes often align management's interests with those of shareholders and may indicate potential resilience amid fluctuating market conditions.

Amidst a backdrop of global economic shifts, Asian markets have been navigating through a mix of optimism and caution, with China's stock markets recently experiencing volatility due to domestic liquidity surges and broader economic concerns. In this dynamic environment, identifying high-growth tech stocks requires a keen eye on innovation potential and resilience in the face of fluctuating market conditions.

Viewing insider transactions for HKT Trust and HKT Limited's ( HKG:6823 ) over the last year, we see that insiders were...

As the Asian markets navigate a complex global landscape marked by economic uncertainties and shifting interest rate expectations, investors are increasingly seeking opportunities that offer both stability and growth potential. Penny stocks, despite their somewhat outdated moniker, remain an intriguing investment area for those looking to explore smaller or newer companies with promising financial health. In this article, we spotlight several penny stocks in Asia that stand out for their...

XtalPi Holdings (SEHK:2228) recently announced a significant milestone as its next-generation PRMT5 inhibitor, PEP08, received regulatory approvals to begin Phase 1 clinical trials for solid tumors. This development underscores the company's advanced capabilities in drug discovery, likely contributing to the impressive 65% rise in its stock price over the last quarter. Alongside broader tech market gains, highlighted by the S&P 500 and Nasdaq reaching new highs, XtalPi's earnings reports...

Cirrus Aircraft (SEHK:2507) reported a strong earnings performance for the half year ended June 30, 2025, with sales rising to USD 594 million from USD 475 million, and net income increasing to USD 65 million, providing a potential catalyst for its share price increase of 42% over the last quarter. These financial results likely underscored confidence in the company amidst a generally robust market environment, where the S&P 500 and Nasdaq hit all-time highs. The company's dividend...

Pop Mart International Group (SEHK:9992) saw its shares rise by 3.15% over the last quarter, a period marked by key developments like its inclusion in both the Hang Seng Index and the Hang Seng China Enterprises Index on September 8, 2025. This addition underscores the company's growing prominence following impressive financial results reported on August 19, 2025, which showed significant year-over-year gains in sales and net income. During this time, major indices like the S&P 500 and Nasdaq...

Akeso (SEHK:9926) recently captured attention by presenting promising data on its cadonilimab therapy at the World Conference on Lung Cancer, highlighting its potential as a breakthrough treatment for immunotherapy-resistant non-small cell lung cancer. Over the last quarter, the company's share price surged 40%, potentially influenced by these significant clinical developments and the awarding of Breakthrough Therapy Designation. The broader market trend, which saw indices like the S&P 500...

Ascletis Pharma (SEHK:1672) recently announced noteworthy advancements related to its investigational drug ASC30, showcasing a promising 75-day half-life in a clinical study, which propelled excitement around potential once-quarterly administration for obesity management. As a result, the company's share price increased by nearly 48% over the last quarter. This rise occurred against a backdrop of broader market gains, with indexes like the Nasdaq and S&P 500 reaching all-time highs,...

Innovent Biologics (SEHK:1801) has recently been part of a significant client announcement, with a new partnership with Fangzhou Inc. aimed at integrating digital health services into innovative therapies for metabolic diseases. This event coincided with the company's share price rising 23% over the last quarter. Aside from this strategic move, the company has also witnessed FDA approval for key investigational drugs such as IBI363, adding weight to its impressive price performance. However,...

Following the recent announcements, Yunfeng Financial Group (SEHK:376) has seen a substantial share price surge of 108% over the past month. The company's impressive earnings announcement on August 28, 2025, which reported a substantial increase in net income to HKD 486 million from HKD 201 million, aligns with market enthusiasm that contributed to the broader market uptrend. Additionally, the new strategic partnership with Ant Digital Technologies and the investment in Pharos Network...

New World Development (SEHK:17) experienced a significant price surge of 66% over the last quarter, likely influenced by its recent strategic discussions to potentially sell its flagship 11 Skies mall for between HKD 15 billion (USD 1.9 billion) amid liquidity pressures. Additionally, the resignation of Dr. Cheng Chi-Kong, Adrian, as a non-executive director may have added to the volatility. These developments occurred alongside broader market trends, where the S&P 500 and Nasdaq set all-time...

Great Eagle Holdings (SEHK:41) probably stands out on your watchlist if you’ve noticed its recent stock performance. While there’s no specific headline driving today’s move, the steady uptick in share price might still prompt investors to ask if something deeper is at play, especially in a market that is often quick to react to subtle changes. Sometimes, the absence of a clear event can spark even more curiosity around a stock’s underlying value and what the market might be sensing in...

Meituan (SEHK:3690) has just released its latest earnings report, and if you’re keeping an eye on the stock, you’re not alone. The update delivered a classic push-pull for investors: sales in the second quarter jumped compared to last year, but net income tumbled, raising new questions about how the company is balancing growth with profitability. This mix of sales strength and weaker bottom-line results is putting Meituan squarely in the spotlight as investors try to figure out if the company...

Most readers would already be aware that BioDlink International's (HKG:1875) stock increased significantly by 18% over...

Key Insights Nongfu Spring's significant insider ownership suggests inherent interests in company's expansion 84% of...